PA
ORIC icon

Profund Advisors’s Oric Pharmaceuticals ORIC Stock Holding History

Profund Advisors’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$653K Sell
51,519
-13,641
-21% -$155K 0.02% 466
2025
Q4 		$533K Buy
65,160
+46,440
+248% +$535K 0.02% 540
2025
Q3 		$225K Buy
+18,720
New +$197K 0.01% 909
2025
Q2 		– Sell
-16,469
Closed -$91.9K – 1033
2025
Q1 		$91.9K Buy
16,469
+5,651
+52% +$49.4K ﹤0.01% 958
2024
Q4 		$87.3K Sell
10,818
-2,684
-20% -$24.6K ﹤0.01% 1078
2024
Q3 		$138K Sell
13,502
-8,359
-38% -$82.6K 0.01% 1090
2024
Q2 		$155K Buy
21,861
+4,175
+24% +$37.4K 0.01% 1017
2024
Q1 		$243K Buy
+17,686
New +$210K 0.01% 970

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Profund Advisors's ORIC Position: Q1 2026 in Review

Profund Advisors reduced its Oric Pharmaceuticals (ORIC) stake by 21% in Q1 2026, selling an estimated $155K and leaving 51,519 shares worth $653K. The position accounts for 0.02% of the portfolio, ranked #466.

Profund Advisors first reported a position in ORIC in Q1 2024 and has held it in 8 quarters since. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Profund Advisors held 51,519 shares of Oric Pharmaceuticals worth $653K as of Q1 2026.
  • Profund Advisors sold 13,641 Oric Pharmaceuticals shares in Q1 2026, an estimated $155K.
  • Oric Pharmaceuticals made up 0.02% of Profund Advisors's portfolio in Q1 2026, its #466 holding.
  • Profund Advisors first reported a position in Oric Pharmaceuticals in Q1 2024 and has held it in 8 quarters since.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Profund Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.